The new name draws from the company’s nearly two decades of work in ryanodine receptor (RyR) biology, which it has used to ...

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

Supporters of the Make America Healthy Again (MAHA) agenda have a message for senators who may be entertaining the idea ...

Addressing stigma, inequity, and access to HIV innovations remains critical to progress in the global HIV response, says IAS ...

Hospitals Open For Now As LA Fires Worsen: Hospitals in Los Angeles County remained operational as of Wednesday evening, though several health systems have shuttered clinical locations and physician ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

Behind every name for a product or drug is someone writing hundreds of possible names. Lieba Golden-Koulendros made a career ...

DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / January 9, 2025 / Can you imagine that in just a few days it became possible to ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...

Also, Penn settled a lawsuit with the German drug manufacturer BioNTech, which, with Pfizer, made the COVID vaccine using ...